EHA Endorsement of ESMO Clinical Practice Guidelines on Hodgkin Lymphoma
EHA and ESMO agreed to collaborate in the production of European Guidelines for different hematological malignancies. For the second workshop in the series participants joined us for the EHA Endorsement of ESMO Clinical Practice Guidelines on Hodgkin Lymphoma.
This workshop was part of a series of six workshops, each focused on the published EHA Guidelines. Registration for the full workshop series was free and the on-demand recordings were made available on the platform. The Guidelines Workshops are designed to raise awareness about EHA producing and endorsing existing guidelines. In addition, the Workshops aimed to disseminate good practices and knowledge for diagnosis and treatment of hematologic diseases and illustrate the application of the guidelines in the real world setting.
During the workshop authors of the Guidelines presented an overview of the guidelines, reviewing diagnostic criteria and discussing treatment strategies. Patient cases were presented to illustrate the application of the guidelines in the real-world setting. The workshops were interactively-designed, allowing the audience to participate in polls and submit questions, which were discussed live during the workshop between the panel members.
Live session date: December 15, 2020
Live session time: 16:00 - 17:15 CET
Chairs: M Federico (Italy), I Aurer (Croatia)
Hematologists, clinicians, transfusion medicine specialists.
- Opening & Welcome
By author I Aurer (Croatia)
- Overview of the Guidelines
M Federico (Italy)
- Clinical case presentation: Intermediate stage Hodgkin lymphoma
T Skrypets (Italy)
- Clinical case presentation: Young female patient with advance-stage HL
D Dujmovic (Croatia)
- Q&A and panel discussion
Chaired by I Aurer (Croatia)
- Closing Remarks
M Federico (Italy)
In the second workshop, Prof Aurer, one of the guidelines authors opened the workshop while Prof Frederico, the other guidelines author, gave an overview of the guidelines, reviewed the Hodgkin lymphoma(HL) epidemiology, the patient allocation, the diagnosis of early/intermediate/advanced HL. Patients cases were presented by Dr Skrypets and Dr Dumjmovic, which illustrated the guidelines application in a patient case with intermediate HL and with advanced HL. The audience participated through interactive polls and post questions were discussed with the expert panel.
Participants of the EHA Guidelines Workshop Series received a total of 4 Continuing Medical Education (CME) points. You can no longer receive CME points by watching the recordings of the Guidelines Workshops.